[Amblyopia. Part 2: Precautionary measures and therapy].
Haase
W
W
haase@uke.uni-hamburg.de
D000065:Accommodation, Ocular; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000550:Amblyopia / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D015858:Anisometropia / Q000175:diagnosis / Q000628:therapy; D001251:Astigmatism / Q000175:diagnosis / Q000628:therapy; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005081:Exercise Therapy; D005139:Eyeglasses; D006801:Humans; D006956:Hyperopia / Q000175:diagnosis; D007223:Infant; D007231:Infant, Newborn; D009184:Mydriatics / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D011932:Reading; D012029:Refraction, Ocular; D012030:Refractive Errors / Q000175:diagnosis / Q000628:therapy; D012307:Risk Factors; D013285:Strabismus / Q000175:diagnosis / Q000517:prevention & control; D013997:Time Factors; D014792:Visual Acuity
D009184:Mydriatics; D001285:Atropine